Copo JJA, Sardiñas PR

Language: Spanish
References: 7
Page: 263-267
PDF size: 102.67 Kb.

ABSTRACT

Neuroendocrine pancreatic tumors are rare and account for 3% of pancreatic tumors approximately. Almost 85 % of them are non-functioning, generally big, located in the intrapancreatic region and diagnosed at advanced staging. Its highest incidence is found in males over 50 years of age. Its symptoms may include abdominal pain, loss of weight and jaundice. The objective of this article was to present an 18 years-old man affected by increase volume in upper hemiabdomen with no relation with other symptoms. On the conclusion of the studies, he was diagnosed with neuroendocrine carcinoma of the pancreatic body, an unusual entity at this age and sex, and he required to undergo distal pancreatectomy with splenectomy.

REFERENCES

1. Franko J, Feng W, Yip L, Genovese E, Moser J. Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients. J Gastrointest Surg. 2010;14:541-8.

2. Vinik A, Woltering E, Warner R, Caplin M, O’Dorisio T, Wiseman G, et al. NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor. Pancreas. 2010;39(6).

3. Colectivo de autores. Manual de Prácticas Médicas. Unidad Funcional de Tumores. Hospital Hermanos Ameijeiras. IV ed. La Habana: ECIMED; 2012.

4. Ehehalt F, Saeger H, Schmidt M. Neuroendocrine Tumors of the Pancreas. The Oncologist. 2009;14:456-67.

5. Klöppel G, Rindi G, Perren A, Komminoth P, Klimstra D. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 2010;456:595-7.

6. Klimstra D, Modlin I, Coppola D, Lloyd R, Suster S. The Pathologic Classification of Neuroendocrine Tumors. A Review of Nomenclature, Grading, and Staging Systems. Pancreas. 2010;39:707-12.

7. Bettini R, Boninsegna L, Mantovani W, Capelli P, Bassi C, Pederzoli P, et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumors. Ann Oncol. 2008;19:903–8.